Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
TCP-25 by In2cure for Wounds: Likelihood of Approval
TCP-25 is under clinical development by In2cure and currently in Phase I for Wounds. According to GlobalData, Phase I drugs...
TCP-25 by In2cure for Epidermolysis Bullosa: Likelihood of Approval
TCP-25 is under clinical development by In2cure and currently in Phase I for Epidermolysis Bullosa. According to GlobalData, Phase I...
TCP-25 by In2cure for Leg Ulcers: Likelihood of Approval
TCP-25 is under clinical development by In2cure and currently in Phase I for Leg Ulcers. According to GlobalData, Phase I...